SDN Members don't see this ad. (About Ads) APhA-ASP urges drug manufacturers and distributors to continually incorporate innovative counterfeit- and tamper-resistant technology into product packaging. Background Statement: Counterfeit drugs have become more prevalent in recent years, particularly with many commonly prescribed medications, such as Lipitor and Viagra. In order to prevent the counterfeiting of drugs and disruption of the drug supply chain, we encourage manufacturers and distributors to collaborate in the development and implementation of innovative technology that ensures the safety and authenticity of the medication. Future technology may include radio frequency identification, chemical taggants, bar coding, and watermarking.